Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder
J Clin Psychiatry 2005;66(11):1492-1493 [letter]
© Copyright 2017 Physicians Postgraduate Press, Inc.
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Self-injurious behavior (SIB) in patients with borderline
personality disorder (BPD), especially cutting, represents a
serious and often intractable clinical problem.1
There are few
validated pharmacologic strategies for managing SIB.1–3
describe our initial experience using glutamate-modulating
agents in 2 patients with BPD and prominent SIBs.